Feature

$Real-World Management and Outcomes of Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated in the United States$

Research Reports

Real-World Management and Outcomes of Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated in the United States

02/18/2020

Andrew J Klink, PhD, MPH

Chadi Nabhan, MD, MBA, FACP

Choo Hyung Lee, MS

JaLyna Laney, RN, OCN

Yin Yang, MS

Anna G Purdum, PharmD, MS

Bruce A Feinberg, DO

Abstract: Given new therapeutic advances that are potentially curative in diffuse large B-cell lymphoma (DLBCL), it is important to understand what has been observed to date in this population to assess improvement...

...

02/18/2020

Journal of Clinical Pathways

Research Reports

Use of Clinical Decision Support and Peer Review to Increase NCCN Guideline Adherence

02/18/2020

Margaret Rausa, PharmD

David Spangler

Stephen Hamilton, MD

Eric Gratias, MD, FAAP

Abstract: eviCore healthcare uses the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines®) to support its proprietary program for medical oncology drug management. The...

...

02/18/2020

Journal of Clinical Pathways

Perspectives

The Oncology Care Model: Performance Period 4 Results and the Next Phase With Two-Sided Risk

12/17/2019

Charles Saunders, MD

Abstract: The Oncology Care Model has reached yet another major milestone, releasing its year-three results in August 2019. Though participants have shared concerns over potential weaknesses in the program, like...

...

12/17/2019

Journal of Clinical Pathways

Research Reports

Quality Improvement Pilot Project to Standardize a Prehabilitation Program for Patients With Esophageal Cancer Receiving Neoadjuvant Chemoradiation

12/17/2019

Ashley E Glode, PharmD, BCOP

S Lindsey Davis, MD

Supriya K Jain, MD

Megan D Marsh, PA

Lisa J Wingrove, RD

Tracey E Schefter, MD

Karyn Goodman, MD, MS

Lindel CK Dewberry, MD

Martin D McCarter, MD

Laura Melton, PhD

Michelle Bunch, CSW

Abstract: A standard treatment recommendation for esophageal cancer patients with stage IB-IIIB disease is for neoadjuvant chemoradiation followed by surgery. This trimodality therapy can be difficult for patients to...

...

12/17/2019

Journal of Clinical Pathways

Perspectives

Integrating Palliative Care Into the Oncology Care Model via Clinical Pathways

11/18/2019

Nikita V Baclig, MD, MPH

Joshua M Liao, MD, MSc, FACP

Abstract: Participants in the Oncology Care Model (OCM) have both the opportunity and need to drive performance by building upon strong historical foundations in oncology clinical pathways and by promoting outcomes...

...

11/18/2019

Journal of Clinical Pathways

From the Field

A Community Practice Perspective on Implementation of Nursing Triage Pathways

11/18/2019

Anne Marie Fraley Rainey, MSN, RN, CHC

Abstract: Clearview Cancer Institute is a private, community practice participating in the Oncology Care Model, an innovative pilot project sponsored by the Center for Medicare and Medicaid Innovation. Over the...

...

11/18/2019

Journal of Clinical Pathways

Special Article

The State of Clinical Pathways: Results From the Inaugural Journal of Clinical Pathways Benchmarking Survey

11/15/2019

Winston Wong, PharmD, Editor-in-Chief

Clinical pathways have become an integral part of oncology care. In use in oncology practices as early as the early 2000s, the prevalence of clinical pathways is expected to increase as the focus on value-based care...

...

11/15/2019

Journal of Clinical Pathways

Research Reports

Use of Biomarker Testing in Lung Cancer Among Puerto Rico and Florida Physicians: Results of a Comparative Study

10/18/2019

Teresita Muñoz-Antonia, PhD

Vani N Simmons, PhD

Steven K Sutton, PhD

Matthew B Schabath, PhD

Iffat Alam

Alberto Chiappori, MD

Gwendolyn P Quinn, PhD

Abstract: Biomarker-driven therapies are the gold standard of treatment in lung cancer. Recent studies suggest a higher prevalence of specific targetable biomarkers among Hispanic/Latinos (H/L) than non-Hispanic...

...

10/18/2019

Journal of Clinical Pathways

Research Reports

Development of a Low Resource Tool for Optimizing Head and Neck Cancer Treatment Delivery Within an Integrated Health Care Delivery System

10/18/2019

Caroline Hudson, MD

David C Wilde, MD

Andrew T Huang, MD

David Hernandez, MD

Anita L Sabichi, MD

George Chen, MD

Peter Gerngross, DDS

Banner Logan, DDS, MD

Ricky Morlen, DMD

Scott Charnitsky, PA

Robert Parke, MD

Vlad C Sandulache, MD, PhD

Abstract: The Veterans Health Administration is the largest nationally integrated health care delivery system in the United States, making it an ideal environment for development of tools designed to streamline cancer diagnosis and...

Abstract: The Veterans...

10/18/2019

Journal of Clinical Pathways

From the Field

Role of a Nurse Navigator and Care Pathways in an Integrated Prostate Cancer Care Program

09/20/2019

Frank dela Rama, RN, MS, AOCNS, AGN-BC

Abstract: An Integrated Prostate Cancer Program was developed and implemented at the Palo Alto Medical Foundation for Health Care, Research and Education in 2006. The Prostate Program offers surgery, radiation...

...

09/20/2019

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Feature

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products